(Q39789952)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19814860%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Arsthinol nanosuspensions: pharmacokinetics and anti-leukaemic activity on NB4 promyelocytic leukaemia cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19814860%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19814860%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Imane Ajana

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19814860%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Alain Astier

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19814860%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

1 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19814860%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pharmacy and Pharmacology

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19814860%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19814860%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19814860%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

1295-1301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19814860%20AND%20SRC:MED&resulttype=core&format=json

Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

Pharmacokinetic properties of the trypanocidal drug melarsoprol

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

Comparison of nanosuspensions and hydroxypropyl-beta-cyclodextrin complex of melarsoprol: pharmacokinetics and tissue distribution in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

Cells involved in the capture of nanoparticles in hematopoietic organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

Arsenic neurotoxicity--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

Pharmacokinetics of melarsoprol in uninfected vervet monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

Properties of melarsamine hydrochloride (Cymelarsan) in aqueous solution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

Trypanothione is the primary target for arsenical drugs against African trypanosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

Drug transport to brain with targeted nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

Metallothionein-I/II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

[Organoarsenicals derived from 2-phenyl-[1,3,2]dithiarsolan-4-yl)-methanol (AsIII) with antileukaemic properties: from trypanosomicides to anticancer drugs]

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

Increased bone marrow toxicity of doxorubicin bound to nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

(2-Phenyl-[1,3,2]dithiarsolan-4-yl)-methanol derivatives show in vitro antileukemic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.10.0004

21 January 2018

Identifiers

DOI

10.1211/JPP.61.10.0004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19814860%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference